MetaADEDB 2.0 @ LMMD
Estrogens, Conjugated (USP)
(VUCAHVBMSFIGAI-TWCWWGPMSA-M)
Structure
SMILES
O=C1CCC2[C@]1(C)CCC1C2CCc2c1ccc(c2)OS(=O)(=O)[O-].[Na+]
Molecular Formula:
C18H21NaO5S
Molecular Weight:
372.411
Log P:
4.0316
Hydrogen Bond Acceptor:
5
Hydrogen Bond Donor:
0
TPSA:
91.88
CAS Number(s):
N/A
Synonym(s)
1.
Estrogens, Conjugated (USP)
2.
Estrogenic Substances, Conjugated
3.
Carentil
4.
Climarest
5.
Climopax
6.
Congest
7.
Conjugated Equine Estrogens
8.
Conjugated Estrogens
9.
Dagynil
10.
Estro-Feminal
11.
Estrogenic Hormones, Conjugated
12.
Estrogens, Conjugated
13.
Femavit
14.
Oestro-Feminal
15.
Oestrofeminal
16.
Prelestrin
17.
Premarin
18.
Presomen
19.
Progens
20.
Transannon
21.
Conjugated Estrogenic Hormones
22.
Conjugated Estrogenic Substances
23.
Equine Estrogens, Conjugated
24.
Estro Feminal
25.
Oestro Feminal
External Link(s)
MeSHD004966
PubChem Compound45357473
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug DependenceFAERS: 2US FAERS
2Drug withdrawal syndromeFAERS: 2US FAERS
3MenorrhagiaFAERS: 2US FAERS
4AngerFAERS: 1US FAERS
5Chest PainFAERS: 1US FAERS
6Deep Vein ThrombosisFAERS: 1US FAERS
7Diabetes MellitusFAERS: 1US FAERS
8Feeling abnormalFAERS: 1US FAERS
9Myocardial InfarctionFAERS: 1US FAERS
10NervousnessFAERS: 1US FAERS
11Night sweatsFAERS: 1US FAERS
12PainFAERS: 1US FAERS
13Pulmonary EmbolismFAERS: 1US FAERS
14SwellingFAERS: 1US FAERS
15ThrombosisFAERS: 1
Canada Vigilance: 1		Canada Vigilance
US FAERS
16UrticariaFAERS: 1
Canada Vigilance: 1		Canada Vigilance
US FAERS
17Abdominal PainCanada Vigilance: 2Canada Vigilance
18Abdominal discomfortCanada Vigilance: 2Canada Vigilance
19Breast tendernessCanada Vigilance: 1Canada Vigilance
20DiscomfortCanada Vigilance: 1Canada Vigilance
21Drug ineffectiveCanada Vigilance: 2Canada Vigilance
22FatigueCanada Vigilance: 1Canada Vigilance
23FlushingCanada Vigilance: 1Canada Vigilance
24HeadacheCanada Vigilance: 2Canada Vigilance
25HypersensitivityCanada Vigilance: 1Canada Vigilance
26Mood swingsCanada Vigilance: 1Canada Vigilance
27NauseaCanada Vigilance: 2Canada Vigilance
28Product substitution issueCanada Vigilance: 2Canada Vigilance
29Reaction to excipientCanada Vigilance: 1Canada Vigilance
30VomitingCanada Vigilance: 2Canada Vigilance
31Vulvovaginal pruritusCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120262

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.